These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 36266969)
1. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020. Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969 [TBL] [Abstract][Full Text] [Related]
2. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis. Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917 [TBL] [Abstract][Full Text] [Related]
3. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210 [TBL] [Abstract][Full Text] [Related]
4. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction. Schupp T; Bertsch T; Reinhardt M; Abel N; Schmitt A; Lau F; Abumayyaleh M; Akin M; Weiß C; Weidner K; Behnes M; Akin I Eur J Prev Cardiol; 2024 Aug; 31(11):1347-1360. PubMed ID: 38513366 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients. Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739 [TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany. Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461 [TBL] [Abstract][Full Text] [Related]
7. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients. Scalvini S; Bernocchi P; Villa S; Paganoni AM; La Rovere MT; Frigerio M Int J Cardiol; 2021 May; 330():106-111. PubMed ID: 33582198 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Traditional Heart Failure Therapies in Patients With Cardiac Amyloidosis and Heart Failure. Yan CL; Gallo RA; Vasquez Martinez M; Rivera Rodriguez B; Trujillo L; Thakkar Rivera N; Hoffman JE Am J Cardiol; 2023 Oct; 204():360-365. PubMed ID: 37573615 [TBL] [Abstract][Full Text] [Related]
9. Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide Study. Garred CH; Zahir D; Butt JH; Ravn PB; Bruhn J; Gislason GH; Fosbøl EL; Torp-Pedersen C; Petrie MC; McMurray JJV; Køber L; Schou M J Am Heart Assoc; 2022 Oct; 11(19):e026187. PubMed ID: 36172925 [TBL] [Abstract][Full Text] [Related]
10. Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence. Janse RJ; Fu EL; Dahlström U; Benson L; Lindholm B; van Diepen M; Dekker FW; Lund LH; Carrero JJ; Savarese G Eur J Heart Fail; 2022 Nov; 24(11):2185-2195. PubMed ID: 35851740 [TBL] [Abstract][Full Text] [Related]
11. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [TBL] [Abstract][Full Text] [Related]
12. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study. Kimmoun A; Cotter G; Davison B; Takagi K; Addad F; Celutkiene J; Chioncel O; Solal AC; Diaz R; Damasceno A; Duengen HD; Filippatos G; Goncalvesova E; Merai I; Metra M; Ponikowski P; Privalov D; Sliwa K; Sani MU; Voors AA; Shogenov Z; Mebazaa A Eur J Heart Fail; 2019 Nov; 21(11):1459-1467. PubMed ID: 31423712 [TBL] [Abstract][Full Text] [Related]
13. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020. Karlström P; Pivodic A; Dahlström U; Fu M Clin Res Cardiol; 2024 Sep; 113(9):1355-1368. PubMed ID: 39186181 [TBL] [Abstract][Full Text] [Related]
15. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001 [TBL] [Abstract][Full Text] [Related]
16. Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. Kruik-Kollöffel WJ; van der Palen J; Doggen CJM; van Maaren MC; Kruik HJ; Heintjes EM; Movig KLL; Linssen GCM PLoS One; 2020; 15(12):e0244231. PubMed ID: 33351823 [TBL] [Abstract][Full Text] [Related]
17. The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta-analysis. Leite M; Sampaio F; Saraiva FA; Diaz SO; Barros AS; Fontes-Carvalho R ESC Heart Fail; 2023 Jun; 10(3):1822-1834. PubMed ID: 36896801 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study. Quiroga B; Ortiz A; Núñez S; Kislikova M; González Sanchidrián S; Broseta JJ; Albines ZS; Escamilla Cabrera B; Rivero Viera Y; Rodriguez Santarelli D; Salanova Villanueva L; Lopez Rodriguez F; Cancho Castellano B; Ibáñez Cerezon M; Gutierrez Rivas CP; Aresté N; Campos Gutiérrez B; Ródenas Gálvez A; Glucksmann Pizá MC; Balda Manzanos S; Soldevila A; Rodríguez Gayo L; Moral Berrio E; Ortega Diaz M; Beltrán Catalán S; Puente García A; Ángel Rojas M; Sosa Barrios RH; Santana Zapatero H; Rangel Hidalgo G; Martinez Canet AM; Díez J; Cardiorenal Med; 2024; 14(1):202-214. PubMed ID: 38513622 [TBL] [Abstract][Full Text] [Related]
19. Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan. Okami S; Lecomte C; Raad H; Aguila M; Mohrova Z; Takeichi M; Tsuchiya T; Ohlmeier C; Evers T; Michel A Sci Rep; 2024 Apr; 14(1):9095. PubMed ID: 38643208 [TBL] [Abstract][Full Text] [Related]
20. Cohort profile: a large EHR-based cohort with linked pharmacy refill and neighbourhood social determinants of health data to assess heart failure medication adherence. Adhikari S; Mukhyopadhyay A; Kolzoff S; Li X; Nadel T; Fitchett C; Chunara R; Dodson J; Kronish I; Blecker SB BMJ Open; 2023 Dec; 13(12):e076812. PubMed ID: 38040431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]